Non-invasive and invasive
- Ductal carcinoma in situ (DCIS)
- Lobular carcinoma in situ (LCIS)
- Invasive ductal carcinoma (IDC)
- Invasive lobular carcinoma (ILC)
- Tubular, medullary, mucinous carcinoma
- Papillary, cribriform, metaplastic carcinoma
Breast Care Center in Turkey
From screening to oncoplastic surgery and reconstruction: rapid diagnosis in 2.5 days, next-generation imaging with artificial intelligence and a team dedicated exclusively to breast health.
International accreditations and recognition
Rapid diagnosis
In breast cancer, every day counts — and uncertainty is the heaviest burden. Our breast health center is organized so that the consultation, imaging, biopsy and multidisciplinary board review are completed in approximately 2.5 days.
You quickly receive a clear diagnosis and a personalized treatment plan, established by the full team: breast surgeon, medical oncologist, radiation oncologist, radiologist and pathologist.
Day 1: consultation, mammography/ultrasound and MRI if needed.
Day 2: image-guided biopsy and rapid pathological evaluation.
Day 3 (½): the multidisciplinary board establishes your treatment plan.
What we treat
From carcinoma in situ to metastatic disease and rare forms — with personalized plans for every patient.
State-of-the-art diagnosis and imaging
Artificial intelligence supports our radiologists by automatically detecting and highlighting potential abnormalities — a decisive advantage for early detection, where early intervention changes outcomes.
Digital mammography + tomosynthesis (3D) + contrast-enhanced mammography.
Breast ultrasound with high frequency and resolution.
3 Tesla MRI dedicated to breast imaging.
Digital PET/CT Omni Legend technology with AI integration, for staging.
Image-guided biopsies — stereotactic, ultrasound-guided or MRI-guided.

Pathology
The right treatment starts with the right diagnosis. Our pathology laboratory rapidly evaluates breast biopsies, with complete immunohistochemistry (ER, PR, HER2, Ki-67) and molecular profiling when needed.
The molecular subtype established by pathology directly guides the choice of treatment — from hormone therapy to anti-HER2 therapies and immunotherapy.

Breast cancer treatment
Your treatment plan is shaped by the tumor's biology, the stage of the disease, genetic mutations and your priorities — always established by the multidisciplinary board:
Breast-conserving surgery — whenever it is oncologically possible.
Mastectomy and oncoplastic surgery — oncological and aesthetic results in the same operation.
Breast reconstruction — immediate or delayed, with an implant or your own tissue.
Chemotherapy — including neoadjuvant (before surgery) to shrink the tumor.
Immunotherapy and targeted therapies — including anti-HER2 therapies, according to the molecular subtype.
Hormone therapy and advanced radiotherapy — for disease control and to prevent recurrence.

Our center
A team dedicated exclusively to the diagnosis and treatment of breast conditions.

Prof. Dr. Kemal Raşa
General Surgery · Breast Surgery
Medical second opinion
Send your medical documents (mammography, ultrasound, MRI, biopsy result) and the breast center team, led by Prof. Dr. Kemal Raşa, will evaluate your case free of charge: diagnosis, treatment options and an estimated cost plan.
Breast center team
Breast surgery, medical oncology, pathology and nuclear medicine — a complete team dedicated to breast health.
Every case is discussed by the breast center's multidisciplinary board.
Testimonials
International patients from around the world, treated at Anadolu.
Life-changing care at Anadolu
Freeman's journey — strength and resilience
Jose Manuel Inclán Embade — from Cuba to Türkiye
Services for international patients
We understand that travelling abroad for cancer treatment can be challenging. Our international patient team takes care of everything.

A dedicated interpreter accompanies you at consultations, investigations and admission — free of charge.
Patients from 65+ countries, assistance in 18 languages — including English.
Full assistance with travel, visa (where required) and accommodation.
Free transfers to and from the airport, with a dedicated driver.
Free evaluation of your documents by the oncology team.
Seamless liaison between doctors, hospital and insurer, with your discharge documents provided in English.
Send your medical documents today — a specialist will contact you the same day.
Frequently asked questions
Can’t find your answer? Talk directly to a patient coordinator — no obligation.
We schedule the consultation, imaging (mammography, ultrasound, MRI if needed), the guided biopsy and rapid pathological evaluation on consecutive days, and the multidisciplinary board establishes your treatment plan immediately afterwards. In approximately 2.5 days you leave with a clear diagnosis and a concrete plan.
Whatever you have available: mammography/ultrasound/MRI (images and reports), the biopsy result with immunohistochemistry (ER, PR, HER2, Ki-67) and recent test results. You will receive a response within 48 hours.
In many cases, yes — breast-conserving surgery is the first option when it is oncologically safe. Oncoplastic surgery combines tumor removal with plastic surgery techniques in the same operation for a good aesthetic result; reconstruction (with an implant or your own tissue) can be immediate or delayed.
Neoadjuvant chemotherapy shrinks the tumor before surgery — it can turn a mastectomy into breast-conserving surgery and shows directly how well the tumor responds to treatment. The decision is made by the multidisciplinary board, based on the molecular subtype.
The molecular subtype guides the treatment: for HER2-positive disease there are targeted anti-HER2 therapies, and for triple-negative disease chemotherapy and immunotherapy may be used, as appropriate. That is why a complete pathological evaluation is essential before any plan.
Yes. Our international patient team speaks English, a medical interpreter accompanies you to consultations and investigations, and your English-speaking patient coordinator stays in constant contact with you and your family, including after you return home.
About us
Anadolu Medical Center is a state-of-the-art multispecialty hospital in Istanbul, established by the Anadolu Foundation in 2005, with non-profit status and a unique affiliation with Johns Hopkins Medicine USA.
Its patient-centered care is certified Planetree Gold, and the quality of its services is accredited by JCI and OECI — on a par with the world's best hospitals.
Contact
Fill in the form and a patient coordinator will contact you the same day. A specialist medical opinion — within 48 hours.
Cumhuriyet Mah., 2255 Sok. No: 341400 Gebze / Kocaeli, Turkey
Response within 48 hours
Request a free review of your case
Our oncology team reviews your documents and comes back with a concrete plan.